Literature DB >> 33712082

Tau assemblies do not behave like independently acting prion-like particles in mouse neural tissue.

Lauren V C Miller1, Aamir S Mukadam1, Claire S Durrant2,3, Marina J Vaysburd4, Taxiarchis Katsinelos1, Benjamin J Tuck1, Sophie Sanford1, Olivia Sheppard2, Claire Knox4, Shi Cheng1, Leo C James4, Michael P Coleman2, William A McEwan5.   

Abstract

A fundamental property of infectious agents is their particulate nature: infectivity arises from independently-acting particles rather than as a result of collective action. Assemblies of the protein tau can exhibit seeding behaviour, potentially underlying the apparent spread of tau aggregation in many neurodegenerative diseases. Here we ask whether tau assemblies share with classical pathogens the characteristic of particulate behaviour. We used organotypic hippocampal slice cultures from P301S tau transgenic mice in order to precisely control the concentration of extracellular tau assemblies in neural tissue. Whilst untreated slices displayed no overt signs of pathology, exposure to recombinant tau assemblies could result in the formation of intraneuronal, hyperphosphorylated tau structures. However, seeding ability of tau assemblies did not titrate in a one-hit manner in neural tissue. The results suggest that seeding behaviour of tau arises at high concentrations, with implications for the interpretation of high-dose intracranial challenge experiments and the possible contribution of seeded aggregation to human disease.

Entities:  

Keywords:  Neurodegeneration; Organotypic hippocampal slice cultures; Prion-like activity; Tau seeded aggregation; Tauopathies

Mesh:

Substances:

Year:  2021        PMID: 33712082      PMCID: PMC7953780          DOI: 10.1186/s40478-021-01141-6

Source DB:  PubMed          Journal:  Acta Neuropathol Commun        ISSN: 2051-5960            Impact factor:   7.801


  42 in total

1.  Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years.

Authors:  Heiko Braak; Dietmar R Thal; Estifanos Ghebremedhin; Kelly Del Tredici
Journal:  J Neuropathol Exp Neurol       Date:  2011-11       Impact factor: 3.685

2.  Accelerated human mutant tau aggregation by knocking out murine tau in a transgenic mouse model.

Authors:  Kunie Ando; Karelle Leroy; Céline Héraud; Zehra Yilmaz; Michèle Authelet; Valèrie Suain; Robert De Decker; Jean-Pierre Brion
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

3.  4-Repeat tau seeds and templating subtypes as brain and CSF biomarkers of frontotemporal lobar degeneration.

Authors:  Eri Saijo; Michael A Metrick; Shunsuke Koga; Piero Parchi; Irene Litvan; Salvatore Spina; Adam Boxer; Julio C Rojas; Douglas Galasko; Allison Kraus; Marcello Rossi; Kathy Newell; Gianluigi Zanusso; Lea T Grinberg; William W Seeley; Bernardino Ghetti; Dennis W Dickson; Byron Caughey
Journal:  Acta Neuropathol       Date:  2019-10-16       Impact factor: 17.088

4.  Seed-competent high-molecular-weight tau species accumulates in the cerebrospinal fluid of Alzheimer's disease mouse model and human patients.

Authors:  Shuko Takeda; Caitlin Commins; Sarah L DeVos; Chloe K Nobuhara; Susanne Wegmann; Allyson D Roe; Isabel Costantino; Zhanyun Fan; Samantha B Nicholls; Alexis E Sherman; Ana T Trisini Lipsanopoulos; Clemens R Scherzer; George A Carlson; Rose Pitstick; Elaine R Peskind; Murray A Raskind; Ge Li; Thomas J Montine; Matthew P Frosch; Bradley T Hyman
Journal:  Ann Neurol       Date:  2016-08-03       Impact factor: 10.422

Review 5.  Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature.

Authors:  Peter T Nelson; Irina Alafuzoff; Eileen H Bigio; Constantin Bouras; Heiko Braak; Nigel J Cairns; Rudolph J Castellani; Barbara J Crain; Peter Davies; Kelly Del Tredici; Charles Duyckaerts; Matthew P Frosch; Vahram Haroutunian; Patrick R Hof; Christine M Hulette; Bradley T Hyman; Takeshi Iwatsubo; Kurt A Jellinger; Gregory A Jicha; Enikö Kövari; Walter A Kukull; James B Leverenz; Seth Love; Ian R Mackenzie; David M Mann; Eliezer Masliah; Ann C McKee; Thomas J Montine; John C Morris; Julie A Schneider; Joshua A Sonnen; Dietmar R Thal; John Q Trojanowski; Juan C Troncoso; Thomas Wisniewski; Randall L Woltjer; Thomas G Beach
Journal:  J Neuropathol Exp Neurol       Date:  2012-05       Impact factor: 3.685

6.  Synthetic tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer's-like tauopathy.

Authors:  Michiyo Iba; Jing L Guo; Jennifer D McBride; Bin Zhang; John Q Trojanowski; Virginia M-Y Lee
Journal:  J Neurosci       Date:  2013-01-16       Impact factor: 6.167

7.  Restriction of multiple divergent retroviruses by Lv1 and Ref1.

Authors:  Theodora Hatziioannou; Simone Cowan; Stephen P Goff; Paul D Bieniasz; Greg J Towers
Journal:  EMBO J       Date:  2003-02-03       Impact factor: 11.598

Review 8.  Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases.

Authors:  Mathias Jucker; Lary C Walker
Journal:  Nat Neurosci       Date:  2018-09-26       Impact factor: 24.884

Review 9.  NEURODEGENERATION. Alzheimer's and Parkinson's diseases: The prion concept in relation to assembled Aβ, tau, and α-synuclein.

Authors:  Michel Goedert
Journal:  Science       Date:  2015-08-07       Impact factor: 47.728

10.  A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity.

Authors:  Zeshan Ahmed; Jane Cooper; Tracey K Murray; Katya Garn; Emily McNaughton; Hannah Clarke; Samira Parhizkar; Mark A Ward; Annalisa Cavallini; Samuel Jackson; Suchira Bose; Florence Clavaguera; Markus Tolnay; Isabelle Lavenir; Michel Goedert; Michael L Hutton; Michael J O'Neill
Journal:  Acta Neuropathol       Date:  2014-02-16       Impact factor: 17.088

View more
  6 in total

Review 1.  Mechanistic Models of Protein Aggregation Across Length-Scales and Time-Scales: From the Test Tube to Neurodegenerative Disease.

Authors:  Georg Meisl; Tuomas P J Knowles; David Klenerman
Journal:  Front Neurosci       Date:  2022-06-30       Impact factor: 5.152

Review 2.  Rodent Modeling of Alzheimer's Disease in Down Syndrome: In vivo and ex vivo Approaches.

Authors:  Clíona Farrell; Paige Mumford; Frances K Wiseman
Journal:  Front Neurosci       Date:  2022-06-07       Impact factor: 5.152

3.  Cholesterol determines the cytosolic entry and seeded aggregation of tau.

Authors:  Benjamin J Tuck; Lauren V C Miller; Taxiarchis Katsinelos; Annabel E Smith; Emma L Wilson; Sophie Keeling; Shi Cheng; Marina J Vaysburd; Claire Knox; Lucy Tredgett; Emmanouil Metzakopian; Leo C James; William A McEwan
Journal:  Cell Rep       Date:  2022-05-03       Impact factor: 9.995

Review 4.  Type-I Interferons in Alzheimer's Disease and Other Tauopathies.

Authors:  Sophie A I Sanford; William A McEwan
Journal:  Front Cell Neurosci       Date:  2022-07-15       Impact factor: 6.147

5.  Spreading of P301S Aggregated Tau Investigated in Organotypic Mouse Brain Slice Cultures.

Authors:  Dhwani S Korde; Christian Humpel
Journal:  Biomolecules       Date:  2022-08-23

Review 6.  Tau Seeding Mouse Models with Patient Brain-Derived Aggregates.

Authors:  Aiko Robert; Michael Schöll; Thomas Vogels
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.